世界のホジキンリンパ腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hodgkin Lymphoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2868
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ホジキンリンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビノレルビン、ANKプログラム、アザシチジン、BMS-986016、BPX-501、その他）、用途別市場規模（病院、クリニック、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ホジキンリンパ腫治療の市場動向
・企業の競争状況、市場シェア
・ホジキンリンパ腫治療の種類別市場規模（ビノレルビン、ANKプログラム、アザシチジン、BMS-986016、BPX-501、その他）
・ホジキンリンパ腫治療の用途別市場規模（病院、クリニック、研究センター）
・ホジキンリンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・ホジキンリンパ腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ホジキンリンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ホジキンリンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ホジキンリンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Cell Medica Limited、Cellular Biomedicine Group, Inc.、Constellation Pharmaceuticals, Inc.、Curis, Inc.、Faron Pharmaceuticals Oy、Fate Therapeutics, Inc.、Gamida Cell Ltd.、Gilead Sciences, Inc.、Incyte Corporation、Merck & Co., Inc.、Mirati Therapeutics Inc.、Molecular Templates Inc.、NantKwest, Inc.）
・結論

Market Analysis and Insights: Global Hodgkin Lymphoma Treatment Market
The global Hodgkin Lymphoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hodgkin Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hodgkin Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hodgkin Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hodgkin Lymphoma Treatment market.

Global Hodgkin Lymphoma Treatment Scope and Market Size
Hodgkin Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hodgkin Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Alocrest
ANK Program
Azacitidine
BMS-986016
BPX-501
Others

Segment by Application
Hospital
Clinic
Research Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cell Medica Limited
Cellular Biomedicine Group, Inc.
Constellation Pharmaceuticals, Inc.
Curis, Inc.
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc.
Gamida Cell Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Curis, Inc.
Faron Pharmaceuticals Oy

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Alocrest
1.2.3 ANK Program
1.2.4 Azacitidine
1.2.5 BMS-986016
1.2.6 BPX-501
1.2.7 Others
1.3 Market by Application
1.3.1 Global Hodgkin Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hodgkin Lymphoma Treatment Market Perspective (2016-2027)
2.2 Hodgkin Lymphoma Treatment Growth Trends by Regions
2.2.1 Hodgkin Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hodgkin Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hodgkin Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hodgkin Lymphoma Treatment Industry Dynamic
2.3.1 Hodgkin Lymphoma Treatment Market Trends
2.3.2 Hodgkin Lymphoma Treatment Market Drivers
2.3.3 Hodgkin Lymphoma Treatment Market Challenges
2.3.4 Hodgkin Lymphoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hodgkin Lymphoma Treatment Players by Revenue
3.1.1 Global Top Hodgkin Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Hodgkin Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hodgkin Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hodgkin Lymphoma Treatment Revenue
3.4 Global Hodgkin Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Hodgkin Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hodgkin Lymphoma Treatment Revenue in 2020
3.5 Hodgkin Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Hodgkin Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Hodgkin Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hodgkin Lymphoma Treatment Breakdown Data by Type
4.1 Global Hodgkin Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hodgkin Lymphoma Treatment Forecasted Market Size by Type (2022-2027)

5 Hodgkin Lymphoma Treatment Breakdown Data by Application
5.1 Global Hodgkin Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hodgkin Lymphoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hodgkin Lymphoma Treatment Market Size (2016-2027)
6.2 North America Hodgkin Lymphoma Treatment Market Size by Type
6.2.1 North America Hodgkin Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Hodgkin Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Hodgkin Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Hodgkin Lymphoma Treatment Market Size by Application
6.3.1 North America Hodgkin Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Hodgkin Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Hodgkin Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Hodgkin Lymphoma Treatment Market Size by Country
6.4.1 North America Hodgkin Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Hodgkin Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hodgkin Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Hodgkin Lymphoma Treatment Market Size by Type
7.2.1 Europe Hodgkin Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hodgkin Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hodgkin Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Hodgkin Lymphoma Treatment Market Size by Application
7.3.1 Europe Hodgkin Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hodgkin Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hodgkin Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Hodgkin Lymphoma Treatment Market Size by Country
7.4.1 Europe Hodgkin Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hodgkin Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hodgkin Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Hodgkin Lymphoma Treatment Market Size by Type
9.2.1 Latin America Hodgkin Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hodgkin Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hodgkin Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Hodgkin Lymphoma Treatment Market Size by Application
9.3.1 Latin America Hodgkin Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hodgkin Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hodgkin Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Hodgkin Lymphoma Treatment Market Size by Country
9.4.1 Latin America Hodgkin Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hodgkin Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cell Medica Limited
11.1.1 Cell Medica Limited Company Details
11.1.2 Cell Medica Limited Business Overview
11.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Introduction
11.1.4 Cell Medica Limited Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.1.5 Cell Medica Limited Recent Development
11.2 Cellular Biomedicine Group, Inc.
11.2.1 Cellular Biomedicine Group, Inc. Company Details
11.2.2 Cellular Biomedicine Group, Inc. Business Overview
11.2.3 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Introduction
11.2.4 Cellular Biomedicine Group, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.2.5 Cellular Biomedicine Group, Inc. Recent Development
11.3 Constellation Pharmaceuticals, Inc.
11.3.1 Constellation Pharmaceuticals, Inc. Company Details
11.3.2 Constellation Pharmaceuticals, Inc. Business Overview
11.3.3 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Introduction
11.3.4 Constellation Pharmaceuticals, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.3.5 Constellation Pharmaceuticals, Inc. Recent Development
11.4 Curis, Inc.
11.4.1 Curis, Inc. Company Details
11.4.2 Curis, Inc. Business Overview
11.4.3 Curis, Inc. Hodgkin Lymphoma Treatment Introduction
11.4.4 Curis, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.4.5 Curis, Inc. Recent Development
11.5 Faron Pharmaceuticals Oy
11.5.1 Faron Pharmaceuticals Oy Company Details
11.5.2 Faron Pharmaceuticals Oy Business Overview
11.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Introduction
11.5.4 Faron Pharmaceuticals Oy Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.5.5 Faron Pharmaceuticals Oy Recent Development
11.6 Fate Therapeutics, Inc.
11.6.1 Fate Therapeutics, Inc. Company Details
11.6.2 Fate Therapeutics, Inc. Business Overview
11.6.3 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Introduction
11.6.4 Fate Therapeutics, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.6.5 Fate Therapeutics, Inc. Recent Development
11.7 Gamida Cell Ltd.
11.7.1 Gamida Cell Ltd. Company Details
11.7.2 Gamida Cell Ltd. Business Overview
11.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Introduction
11.7.4 Gamida Cell Ltd. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.7.5 Gamida Cell Ltd. Recent Development
11.8 Gilead Sciences, Inc.
11.8.1 Gilead Sciences, Inc. Company Details
11.8.2 Gilead Sciences, Inc. Business Overview
11.8.3 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Introduction
11.8.4 Gilead Sciences, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.8.5 Gilead Sciences, Inc. Recent Development
11.9 Incyte Corporation
11.9.1 Incyte Corporation Company Details
11.9.2 Incyte Corporation Business Overview
11.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Introduction
11.9.4 Incyte Corporation Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.9.5 Incyte Corporation Recent Development
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Company Details
11.10.2 Merck & Co., Inc. Business Overview
11.10.3 Merck & Co., Inc. Hodgkin Lymphoma Treatment Introduction
11.10.4 Merck & Co., Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.10.5 Merck & Co., Inc. Recent Development
11.11 Mirati Therapeutics Inc.
11.11.1 Mirati Therapeutics Inc. Company Details
11.11.2 Mirati Therapeutics Inc. Business Overview
11.11.3 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Introduction
11.11.4 Mirati Therapeutics Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.11.5 Mirati Therapeutics Inc. Recent Development
11.12 Molecular Templates Inc.
11.12.1 Molecular Templates Inc. Company Details
11.12.2 Molecular Templates Inc. Business Overview
11.12.3 Molecular Templates Inc. Hodgkin Lymphoma Treatment Introduction
11.12.4 Molecular Templates Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.12.5 Molecular Templates Inc. Recent Development
11.13 NantKwest, Inc.
11.13.1 NantKwest, Inc. Company Details
11.13.2 NantKwest, Inc. Business Overview
11.13.3 NantKwest, Inc. Hodgkin Lymphoma Treatment Introduction
11.13.4 NantKwest, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021)
11.13.5 NantKwest, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Alocrest
Table 3. Key Players of ANK Program
Table 4. Key Players of Azacitidine
Table 5. Key Players of BMS-986016
Table 6. Key Players of BPX-501
Table 7. Key Players of Others
Table 8. Global Hodgkin Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hodgkin Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Hodgkin Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Hodgkin Lymphoma Treatment Market Share by Regions (2016-2021)
Table 12. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Hodgkin Lymphoma Treatment Market Share by Regions (2022-2027)
Table 14. Hodgkin Lymphoma Treatment Market Trends
Table 15. Hodgkin Lymphoma Treatment Market Drivers
Table 16. Hodgkin Lymphoma Treatment Market Challenges
Table 17. Hodgkin Lymphoma Treatment Market Restraints
Table 18. Global Hodgkin Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Hodgkin Lymphoma Treatment Market Share by Players (2016-2021)
Table 20. Global Top Hodgkin Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hodgkin Lymphoma Treatment as of 2020)
Table 21. Ranking of Global Top Hodgkin Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Hodgkin Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hodgkin Lymphoma Treatment Product Solution and Service
Table 25. Date of Enter into Hodgkin Lymphoma Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hodgkin Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Hodgkin Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Hodgkin Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Hodgkin Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Hodgkin Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Hodgkin Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Hodgkin Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Hodgkin Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Hodgkin Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Hodgkin Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Hodgkin Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Hodgkin Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Hodgkin Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Hodgkin Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Hodgkin Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Hodgkin Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Hodgkin Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Hodgkin Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Hodgkin Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Hodgkin Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Hodgkin Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Hodgkin Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Hodgkin Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Hodgkin Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Cell Medica Limited Company Details
Table 66. Cell Medica Limited Business Overview
Table 67. Cell Medica Limited Hodgkin Lymphoma Treatment Product
Table 68. Cell Medica Limited Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 69. Cell Medica Limited Recent Development
Table 70. Cellular Biomedicine Group, Inc. Company Details
Table 71. Cellular Biomedicine Group, Inc. Business Overview
Table 72. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Product
Table 73. Cellular Biomedicine Group, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 74. Cellular Biomedicine Group, Inc. Recent Development
Table 75. Constellation Pharmaceuticals, Inc. Company Details
Table 76. Constellation Pharmaceuticals, Inc. Business Overview
Table 77. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Product
Table 78. Constellation Pharmaceuticals, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 79. Constellation Pharmaceuticals, Inc. Recent Development
Table 80. Curis, Inc. Company Details
Table 81. Curis, Inc. Business Overview
Table 82. Curis, Inc. Hodgkin Lymphoma Treatment Product
Table 83. Curis, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 84. Curis, Inc. Recent Development
Table 85. Faron Pharmaceuticals Oy Company Details
Table 86. Faron Pharmaceuticals Oy Business Overview
Table 87. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Product
Table 88. Faron Pharmaceuticals Oy Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 89. Faron Pharmaceuticals Oy Recent Development
Table 90. Fate Therapeutics, Inc. Company Details
Table 91. Fate Therapeutics, Inc. Business Overview
Table 92. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Product
Table 93. Fate Therapeutics, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 94. Fate Therapeutics, Inc. Recent Development
Table 95. Gamida Cell Ltd. Company Details
Table 96. Gamida Cell Ltd. Business Overview
Table 97. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Product
Table 98. Gamida Cell Ltd. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 99. Gamida Cell Ltd. Recent Development
Table 100. Gilead Sciences, Inc. Company Details
Table 101. Gilead Sciences, Inc. Business Overview
Table 102. Gilead Sciences, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 103. Gilead Sciences, Inc. Recent Development
Table 104. Incyte Corporation Company Details
Table 105. Incyte Corporation Business Overview
Table 106. Incyte Corporation Hodgkin Lymphoma Treatment Product
Table 107. Incyte Corporation Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 108. Incyte Corporation Recent Development
Table 109. Merck & Co., Inc. Company Details
Table 110. Merck & Co., Inc. Business Overview
Table 111. Merck & Co., Inc. Hodgkin Lymphoma Treatment Product
Table 112. Merck & Co., Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 113. Merck & Co., Inc. Recent Development
Table 114. Mirati Therapeutics Inc. Company Details
Table 115. Mirati Therapeutics Inc. Business Overview
Table 116. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Product
Table 117. Mirati Therapeutics Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 118. Mirati Therapeutics Inc. Recent Development
Table 119. Molecular Templates Inc. Company Details
Table 120. Molecular Templates Inc. Business Overview
Table 121. Molecular Templates Inc. Hodgkin Lymphoma Treatment Product
Table 122. Molecular Templates Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 123. Molecular Templates Inc. Recent Development
Table 124. NantKwest, Inc. Company Details
Table 125. NantKwest, Inc. Business Overview
Table 126. NantKwest, Inc. Hodgkin Lymphoma Treatment Product
Table 127. NantKwest, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 128. NantKwest, Inc. Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hodgkin Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Alocrest Features
Figure 3. ANK Program Features
Figure 4. Azacitidine Features
Figure 5. BMS-986016 Features
Figure 6. BPX-501 Features
Figure 7. Others Features
Figure 8. Global Hodgkin Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Research Center Case Studies
Figure 12. Hodgkin Lymphoma Treatment Report Years Considered
Figure 13. Global Hodgkin Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Hodgkin Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hodgkin Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Hodgkin Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 17. Global Hodgkin Lymphoma Treatment Market Share by Players in 2020
Figure 18. Global Top Hodgkin Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hodgkin Lymphoma Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Hodgkin Lymphoma Treatment Revenue in 2020
Figure 20. Global Hodgkin Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Hodgkin Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Hodgkin Lymphoma Treatment Market Share by Type (2016-2027)
Figure 24. North America Hodgkin Lymphoma Treatment Market Share by Application (2016-2027)
Figure 25. North America Hodgkin Lymphoma Treatment Market Share by Country (2016-2027)
Figure 26. United States Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Hodgkin Lymphoma Treatment Market Share by Type (2016-2027)
Figure 30. Europe Hodgkin Lymphoma Treatment Market Share by Application (2016-2027)
Figure 31. Europe Hodgkin Lymphoma Treatment Market Share by Country (2016-2027)
Figure 32. Germany Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Hodgkin Lymphoma Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Hodgkin Lymphoma Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Hodgkin Lymphoma Treatment Market Share by Region (2016-2027)
Figure 42. China Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Hodgkin Lymphoma Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Hodgkin Lymphoma Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Hodgkin Lymphoma Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Hodgkin Lymphoma Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Hodgkin Lymphoma Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Hodgkin Lymphoma Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Hodgkin Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Cell Medica Limited Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 62. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 63. Constellation Pharmaceuticals, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 64. Curis, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 65. Faron Pharmaceuticals Oy Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 66. Fate Therapeutics, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 67. Gamida Cell Ltd. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 68. Gilead Sciences, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 69. Incyte Corporation Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 70. Merck & Co., Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 71. Mirati Therapeutics Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 72. Molecular Templates Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 73. NantKwest, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

世界のホジキンリンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Hodgkin's Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2869 2021年4月 92Pages
QYResearch社発行の本調査資料では、ホジキンリンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルキル化抗腫瘍剤、抗腫瘍性抗腫瘍剤、抗腫瘍剤ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗タボライト抗腫瘍剤、アントラ...

世界の非ホジキンリンパ腫（NHL）市場規模・現状・予測（2021年-2027年）

Global Non Hodgkin Lymphoma (NHL) Market Size, Status and Forecast 2021-2027
QYR2104Z4154 2021年4月 95Pages
QYResearch社発行の本調査資料では、非ホジキンリンパ腫（NHL）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（標準型、高級型）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の非ホジキンリンパ腫治療薬市場規模・現状・予測（2021年-2027年）

Global Non-Hodgkin Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4165 2021年4月 97Pages
QYResearch社発行の本調査資料では、非ホジキンリンパ腫治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法）、用途別市場規模（臨床研究、治療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国...

世界の非ホジキンリンパ腫治療薬市場 2021：企業別、地域別、種類・用途別

Global Non-Hodgkin Lymphoma Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z10040 2021年4月 109Pages
当調査資料では、非ホジキンリンパ腫治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。非ホジキンリンパ腫治療薬の種類別市場規模（化学療法、標的療法）、用途別市場規模（臨床研究、治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東...

世界の犬リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Canine Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1083 2021年4月 95Pages
QYResearch社発行の本調査資料では、犬リンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルキル化剤、コルチコステロイド、プリン類似体、代謝拮抗剤、免疫調節剤、その他）、用途別市場規模（獣医病院・クリニック、外来、在宅、その他...

世界の犬リンパ腫治療市場規模・現状・予測（2021年-2027年）

世界のリンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Lymphoma Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z3505 2021年4月 91Pages
QYResearch社発行の本調査資料では、リンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（ホジキンリンパ腫、非ホジキンリンパ腫）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界のバーキットリンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Burkitt Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1033 2021年4月 99Pages
QYResearch社発行の本調査資料では、バーキットリンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の低悪性度リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Indolent Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3087 2021年4月 96Pages
QYResearch社発行の本調査資料では、低悪性度リンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BI-836826、ALT-803、BMS-986016、CC-122、その他）、用途別市場規模（病院、クリニック、その他）、主要地...

世界のマントル細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Mantle Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3555 2021年4月 92Pages
QYResearch社発行の本調査資料では、マントル細胞リンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アカラブルチニブ、JCAR-017、JNJ-64052781、アカリシブ、IGN-002、IMGN-529、AFM-11、その他...

世界のホジキンリンパ腫治療市場規模・現状・予測（2021年-2027年） Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
世界の非ホジキンリンパ腫（NHL）市場規模・現状・予測（2021年-2027年） Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver. Market An…
世界の非ホジキンリンパ腫治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-Hodgkin Lymphoma Therapeutics Market The global Non-Hodgkin Lymphoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
世界の非ホジキンリンパ腫治療薬市場 2021：企業別、地域別、種類・用途別 The Non-Hodgkin Lymphoma Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
世界のリンパ腫治療市場規模・現状・予測（2021年-2027年） Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control Market Analysis and Insights: Global L…